Ipca Laboratories
JMD)[3] | |
Products | Pharmaceutical drugs, generic drugs, antiviral drugs, over-the-counter drugs, vaccines, |
---|---|
Revenue | ₹5,896 crore (US$740 million) (FY22)[4] |
₹884 crore (US$110 million) (FY22)[4] | |
Number of employees | 12000 (2015) |
Subsidiaries | CCPL Software,[2] Ipca Traditional Remedies[5] |
Website | www |
Ipca Laboratories Limited is an Indian multinational
active pharmaceutical ingredients (APIs). Ipca sells these APIs and their intermediates globally.[6] It produces more than 150 formulations that include oral liquids, tablets, dry powders, and capsules.[7]
History
It was founded by group of businessmen and medical professionals in 1949.[8] In 1975, the management of the company was taken over by Amitabh Bachchan, Ajitabh Bachchan, Jaya Bachchan, M.R. Chandurkar, P.C. Godha.[9] In 1997, the Bachchan family sold their 36% holding in Ipca Laboratories to, at the time, the company's four whole time directors.[10]
In 2004, Forbes selected Ipca, for the second consecutive year as one among the first 200 'Best under a billion company' in Asia.[9]
It also got certification from
US Food and Drug Administration (FDA), UK-Medicines and Healthcare products Regulatory Agency (MHRA), South Africa-Medicines Control Council (MCC), Brazil-Brazilian National Health Vigilance Agency (ANVISA) and Australia-Therapeutic Goods Administration (TGA). On 29 Jan 2016 the FDA issued a warning letter, WL: 320-16-07, for failure to comply with good manufacturing processes (GMP) under section 21 of the code of federal regulations (21 CFR).[11]
Products and operations
The various kinds of drug intermediates that the company manufactures include theobromine, acetylthiophene, and p-bromotoluene. It is present in over 36 countries of
active pharmaceutical ingredients
(API).
References
- ^ "Ipca Laboratories Ltd. :: Contact Us :: India Offices". Ipcalabs.com. Archived from the original on 13 November 2010. Retrieved 1 December 2010.
- ^ a b "Ipca Laboratories targets Rs 425cr turnover this year". Expressindia.com. 15 September 2000. Retrieved 2 December 2010.
- ^ "Pawan Kothari". Expresspharmaonline.com. 31 August 2010. Retrieved 2 December 2010.
- ^ a b "Ipca Labs Q4 net profit declines 19% at Rs 130 crore on higher expenses". Business Standard. 24 May 2022. Retrieved 3 February 2023.
- ^ "Ipca Laboratories Ltd plans to diversify into Ayurveda business". AyurvedNews.com. Archived from the original on 7 July 2011. Retrieved 2 December 2010.
- ^ "Ipca Laboratories". Business.mapsofindia.com. Retrieved 1 December 2010.
- ^ "Interview of Mr. AK Jain, Executive Director, Ipca Laboratories Ltd". Indiainfoline.com. Retrieved 1 December 2010.
- ^ "IPCA Laboratories Ltd Term Buy Call: StocksIdea.com | TopNews". Topnews.in. 15 December 2009. Retrieved 1 December 2010.
- ^ a b "Ipca Laboratories Ltd Background details about Company Profile". Indiainfoline.com. 9 August 1988. Retrieved 1 December 2010.
- ^ Tiwari, Vibha (7 February 1997). "Bachchans To Sell 36% Stake In Ipca Labs To Directors". Business Standard India. Retrieved 16 July 2022.
- ^ "WL: 320-16-07". FDA.gov. Retrieved 16 February 2016.